1067 Companies
Bionomics Limited, based in Australia, is a company that focuses on the research and development of therapeutics for cancer and diseases of the central nervous system. Their portfolio includes prog...
Bionomics Ltd Annual Report 2023Rockville, Maryland-based biopharmaceutical company, Supernus Pharmaceuticals, Inc. has been actively focusing on research and development, as well as commercialization of innovative products for t...
Supernus Pharmaceuticals Annual Report 2023Biomerica, Inc., a leading biomedical technology company, has been making significant strides in the development, patenting, manufacturing, and marketing of innovative diagnostic and therapeutic pr...
Biomerica, Inc. Annual Report 2023Patrys Limited, an Australian company, develops and commercializes antibody technologies for the treatment of cancer. Its lead technology, Deoxymab 3E10, is a DNA damage-repair antibody that inhibi...
Patrys Limited Annual Report 2023Gene editing company CRISPR Therapeutics AG is making significant strides in the development of gene-based medicines for a wide range of serious diseases by leveraging its highly innovative Cluster...
CRISPR Annual Report 2023NewMarket Corporation (NEU), a leading manufacturer and seller of petroleum additives, is continuing its growth trajectory by expanding its product offerings. The company's subsidiaries create lubr...
NewMarket Annual Report 2023Adaptive Biotechnologies Corporation, a leading commercial-stage biotech firm, has made strides in developing an advanced immune medicine platform to aid in the diagnosis and treatment of diseases....
Adaptive Biotechnologies Annual Report 2023Texas-based Atrion Corporation, along with its subsidiaries, engages in the development, manufacture, and sale of innovative fluid delivery, cardiovascular, and ophthalmology products across the Un...
Atrion Corp. Annual Report 2020Cambridge-based precision therapy company, Blueprint Medicines Corporation, is making strides in the development of genomic medicines for a variety of cancers and blood disorders. Its portfolio inc...
Blueprint Medicines Annual Report 2023Tivity Health, Inc. is a company that specializes in offering fitness and health improvement programs to the population aged over 50. The company has established itself as a leader in providing net...
Tivity Health, Inc. Annual Report 2020PolyNovo Biomaterials Pty Ltd. is a leading developer and owner of a novel biodegradable polymer technology known as NovoSorb TM. The company specializes in developing regenerative devices for reco...
PolyNovo Annual Report 2023Chapel Hill-based biopharmaceutical company, Tenax Therapeutics, Inc., has announced the development and commercialization of pharmaceutical products that include imatinib for the treatment of pulm...
Tenax Therapeutics, Inc. Annual Report 2023DURECT Corporation, a leading biopharmaceutical player, has made significant strides in the field of drug research and development. The company's focus on epigenetic regulation and pharmaceutical p...
Durect Corp. Annual Report 2023Catabasis Pharmaceuticals is a company committed to finding innovative therapies to improve the lives of patients suffering from Duchenne muscular dystrophy. The company's lead program, edasalonexe...
Catabasis Pharmaceuticals, Inc. Annual Report 2019C4X Discovery Holdings plc, a British drug discovery company, is making waves in the industry with its innovative platforms and promising product pipeline. At the core of the company's technology i...
C4X Discovery Annual Report 2023